Login or sign up
For business

DiaKine Therapeutics

4.0· 8 reviews
Average ratingGreat
4.0/ 5

Based on 8 reviews

538%
425%
338%
20%
10%
Ask AI

Ask Trustburn about DiaKine Therapeutics

Based on 8 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Pierre Dillinger
Reviews 1

DiaKine Therapeutics has been a game-changer for me. Their innovative products and solutions have greatly improved my health. The company website is well-designed and easy to navigate. The customer service has been exceptional, with quick and helpful responses to my inquiries. I highly recommend DiaKine Therapeutics to anyone in need of their services.

Mabel Casimiro
Reviews 1

I recently used the services provided by this company, and I must say I was impressed. The website was easy to use and had all the necessary information. The level of customer service I received was outstanding. They were prompt and efficient in addressing my concerns. I highly recommend them for anyone in need of their services.

Crystal Marcano
Reviews 1

I had a great experience with DiaKine Therapeutics. Their website is user-friendly and easy to navigate. The information provided was clear and comprehensive. The customer service was excellent, with prompt and helpful responses to my inquiries. Overall, I am very satisfied with the company and would highly recommend them.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About DiaKine Therapeutics

DiaKine Therapeutics, Inc. is a development stage company commercializing novel immune modulators for the treatment of diabetes and related complications. These drugs have the potential to stop the progression of diabetes and reverse damage already caused by the disease. Therapeutics under development by DiaKine include: adjunct therapy to islet cell transplants (in Phase 2 clinical trial), halting the progression of type 1 diabetes in newly diagnosed adults, treatment and prevention of Latent Autoimmune Diabetes of Adults (LADA), treatment and prevention of insulin requiring type 2 diabetic, treatment and prevention of diabetes complications. DiaKine would like to thank the National Institute of Diabetes & Digestive & Kidney Diseases/National Institutes of Health (NIDDK/NIH) for producing the clinical trials supplies for the trial.